All News #Library
Others
Stada and Xbrane gain EU approval for biosimilar Ximluci
11 Nov 2022 //
PHARMATIMES
STADA and Xbrane welcome EMA positive opinion for ranibizumab biosimilar
16 Sep 2022 //
STADA
Russia Launches Omalizumab; Remsima Sales Soar; Xbrane Trial Results
19 Feb 2022 //
CENTERFORBIOSIMILARS
Biogen and Xbrane Announce Commercialization and License Agreement for CIMZIA
07 Feb 2022 //
GLOBENEWSWIRE
Xbrane has initiated development of two new biosimilar candidates
13 Dec 2021 //
PRESS RELEASE

Market Place
Sourcing Support